Investor Presentaiton
Back to Table of Contents
CC1: Composition of regulatory capital
(in $ millions)
a2
аз
ад
Q2 2023
Revised Basel III
Q1 2023
Q4 2022
Q3 2022
Basel III
Basel III
Basel III
b
Source based on reference numbers/letters of the
balance sheet under the regulatory scope of
consolidation (1)
30
31
Additional Tier 1 capital: instruments
Directly issued qualifying Additional Tier 1 instruments plus related stock surplus
of which: classified as equity under applicable accounting standards
8,075
8,075
8,075
8,075
8,075
8,075
7,052
7,052
32
33
of which: classified as liabilities under applicable accounting standards
Directly issued capital instruments subject to phase out from additional Tier 1
34
Additional Tier 1 instruments (and CET1 instruments not included in row 5) issued by subsidiaries and held by
third parties (amount allowed in group AT1)
93
104
106
110
bb
35
36
of which: instruments issued by subsidiaries subject to phase out
Additional Tier 1 capital before regulatory adjustments
8,168
8,179
8,181
7,162
Additional Tier 1 capital: regulatory adjustments
37
Investments in own Additional Tier 1 instruments
38
Reciprocal cross holdings in Additional Tier 1 instruments.
39
Non-significant investments in the capital of banking, financial and insurance entities, net of eligible short
positions (amount above 10% threshold)
Significant investments in the capital of banking, financial and insurance entities that are outside the scope of
40
regulatory consolidation, net of eligible short positions
41
Other deductions from Tier 1 capital as determined by OSFI
42
Regulatory adjustments applied to Additional Tier 1 due to insufficient Tier 2 to cover deductions
43
Total regulatory adjustments to Additional Tier 1 capital
44
Additional Tier 1 capital (AT1)
45
Tier 1 capital (T1 = CET1 + AT1)
Scotiabank
8,168
63,688
8,179
62,317
8,181
61,262
7,162
58,801
b
Supplementary Regulatory Capital Disclosure
Page 22 of 88View entire presentation